CLINICAL_TRIALS
trial_result
· 2024-02-29
Clinical Trial Update: Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients [Phase 3]
Summary
Phase 3 trial assessing repeated administrations of NurOwn for amyotrophic lateral sclerosis (ALS) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brainstorm-Cell Therapeutics | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 3 | Status: COMPLETED | Results posted: 2024-02-29